image
Monte Rosa Therapeutics, Inc. GLUE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.63
3.12 %
$ 285 M
Market Cap
38.58
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
11.91%
EBIT Estimate
30.24%
Net Income Estimate
--16.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Monte Rosa Therapeutics, Inc.
image
GLUE has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart GLUE

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart GLUE

image
$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart GLUE

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)20232023202420242025202520262026202720272028202820292029